Y-Intercept (HK)’s Cogent Biosciences COGT Stock Holding History

Y-Intercept (HK)’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	48,220 +13,461	+39%	+$471K	0.04%	745
2026 Q1	$1.34M	Sell	34,759 -60,045	-63%	-$2.22M	0.03%	914
2025 Q4	$3.37M	Buy	+94,804	New	+$2.67M	0.08%	374
2025 Q3	–	Sell	-116,127	Closed	-$834K	–	1628
2025 Q2	$834K	Buy	116,127 +72,628	+167%	+$403K	0.02%	1020
2025 Q1	$261K	Sell	43,499 -31,538	-42%	-$247K	0.02%	953
2024 Q4	$585K	Buy	75,037 +43,472	+138%	+$433K	0.04%	657
2024 Q3	$341K	Sell	31,565 -13,294	-30%	-$129K	0.02%	957
2024 Q2	$378K	Buy	+44,859	New	+$340K	0.02%	940
2024 Q1	–	Sell	-14,618	Closed	-$86K	–	1419
2023 Q4	$86K	Buy	+14,618	New	+$112K	0.01%	1116

Other funds holding COGT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Y-Intercept (HK)'s COGT Position: Q2 2026 in Review

Y-Intercept (HK) increased its Cogent Biosciences (COGT) stake by 39% in Q2 2026, buying an estimated $471K and bringing the position to 48,220 shares worth $1.87M. The position accounts for 0.04% of the portfolio, ranked #745.

Y-Intercept (HK) first reported a position in COGT in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.37M in Q4 2025. 17 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Y-Intercept (HK) held 48,220 shares of Cogent Biosciences worth $1.87M as of Q2 2026.
Y-Intercept (HK) bought 13,461 Cogent Biosciences shares in Q2 2026, an estimated $471K.
Cogent Biosciences made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #745 holding.
Y-Intercept (HK) first reported a position in Cogent Biosciences in Q4 2023 and has held it in 9 quarters since.
Y-Intercept (HK)'s Cogent Biosciences position peaked at $3.37M in Q4 2025.
17 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.